MedTrace Logo

Pain Increases After Shoulder Injection

NCT05438277 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 421

Last updated 2023-03-07

Study results available
· View outcomes & findings →

Summary

Compare FLARE reactions (increase in VAS by two or more points) in the first 48 hours following a shoulder injection.

Conditions

  • Shoulder Pain

Interventions

DRUG

Methylprednisolone (MPA)

injection into subacromial or glenohumeral space with MPA

DRUG

Triamcinolone Acetonide (TA)

injection into subacromial or glenohumeral space with TA

Sponsors & Collaborators

  • Campbell Clinic

    lead OTHER

Principal Investigators

  • Tyler Brolin, MD · Campbell Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-08-31
Completion
2022-09-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05438277 on ClinicalTrials.gov